This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by French, J. Articles by Donehower, L. A. Search for Related Content PubMed PubMed Citation Articles by French, J. Articles by Donehower, L. A. Social Bookmarking                         What's this?

The Nature of the Heterozygous Trp53 Knockout Model for Identifi cation of Mutagenic Carcinogens

National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina

Richard D. Storer

Merck Research Laboratories, West Point, Pennsylvania

Lawrence A. Donehower

Baylor College of Medicine, Houston, Texas

The heterozygous Trp 53 null allele C57BL/6 (N5) mouse is susceptible to the rapid development of neoplasia by mutagenic carcinogens relative to control strains. This mouse model of chemical carcinogenesis demonstrates 1) dose-related rapid induction of tumors (26 wks), 2) multiple sites of carcinogen-specifi c tissue susceptibility, and 3) carcinogen-induced loss of heterozygosity involving the Trp53 wild-type allele or a p53 haploinsufficiency permitting mutation of other critical protooncogenes and/or inactivation of tumor suppressor genes driving tumorigenesis. Demonstration of mutation or loss ofheterozygosity involving the Trp53 locus is consistent with a common finding in human cancers and supports extrapolation between rodents and humans. Using diverse experimental protocols, almost all mutagenic rodent carcinogens (including all mutagens that are carcinogenic to humans), but not nonmutagenic rodent carcinogens, induce tumors within 26 weeks of continuous exposure. These characteristics and results indicate that the mouse heterozygous for the Trp53 null allele may be of significant use for the prospective identification of mutagenic carcinogens of potential risk to human health.

Key Words: p53 haploinsufficiency • risk assessment • C57BL/6 (N5) mouse • loss of heterozygosity.

Toxicologic Pathology, Vol. 29, No. 1 suppl, 24-29 (2001)
DOI: 10.1080/019262301753178456


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. J. Jonker, O. Bruning, M. van Iterson, M. M. Schaap, T. V. van der Hoeven, H. Vrieling, R. B. Beems, A. de Vries, H. van Steeg, T. M. Breit, et al. Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models Carcinogenesis, October 1, 2009; 30(10): 1805 - 1812. [Abstract] [Full Text] [PDF]

				M. J. Santostefano, D. J. Hoivik, and R. T. Miller Investigations of Clofibrate in Alternative Carcinogenicity Models International Journal of Toxicology, September 1, 2005; 24(5): 285 - 288. [Full Text] [PDF]

				C. E. Torrey, J. A. Campbell, D. J. Hoivik, R. T. Miller, J. S. Allen, P. C. Mann, K. Selinger, D. Rickert, P. M. Savina, and M. J. Santostefano Evaluation of the Carcinogenic Potential of Clofibrate in the p53+/- Mouse International Journal of Toxicology, September 1, 2005; 24(5): 289 - 299. [Abstract] [Full Text] [PDF]

				D. J. Hoivik, J. S. Allen, H. G. Wall, J. B. Nold, R. T. Miller, and M. J. Santostefano Studies Evaluating the Utility of N-Methyl-N-Nitrosourea as a Positive Control in Carcinogenicity Studies in the p53+/- Mouse International Journal of Toxicology, September 1, 2005; 24(5): 349 - 356. [Abstract] [Full Text] [PDF]

				J. M. Ward and D. E. Devor-Henneman Mouse Models of Human Familial Cancer Syndromes Toxicol Pathol, January 1, 2004; 32(1_suppl): 90 - 98. [Abstract] [PDF]

				Y. Matsuoka, K. Fukamachi, T. Hamaguchi, H. Toriyama-Baba, H. Kawaguchi, M. Kusunoki, H. Yoshida, and H. Tsuda Rapid Emergence of Mammary Preneoplastic and Malignant Lesions in Human c-Ha-ras Proto-Oncogene Transgenic Rats: Possible Application for Screening of Chemopreventive Agents Toxicol Pathol, October 1, 2003; 31(6): 632 - 637. [Abstract] [PDF]

				S. R. Payne and C. J. Kemp p27 Kip1 (Cdkn1b)-Deficient Mice Are Susceptible to Chemical Carcinogenesis and May Be a Useful Model for Carcinogen Screening Toxicol Pathol, June 1, 2003; 31(4): 355 - 363. [Abstract] [PDF]

				Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment Statement on ILSI/HESI Research Programme on Alternative Cancer Models Toxicol Pathol, February 1, 2003; 31(2): 254 - 257. [PDF]